期刊文献+

他汀类药物对炎性关节炎的潜在治疗作用 被引量:4

Potential use of statins in the prevention of inflammatory arthritis
下载PDF
导出
摘要 他汀类药物,即3-羟基-3-甲基戊二酰辅酶A(HMA-CoA)还原酶抑制剂,可减少动脉粥样硬化的形成和心血管事件的发病率及死亡率。上述作用源自该类药物对胆固醇代谢的影响以及下调低密度脂蛋白的合成。目前越来越多的证据显示,除上述作用外,他汀类药物还有更广泛的作用,包括对炎症途径的影响、免疫调节活性、控制类风湿关节炎病情的活动、降低血管危险性和对炎性关节炎的潜在治疗作用。 HMG-CoA reductase inhibitors (statins) reduce risk of atherogenesis as well as cardiovascular morbidity and mortality by the modulation of cholesterol metabolism and inhibition of the LDL synthesis. More and more evidences support statins' potential anti-inflammation, immunomodulation,suppression of RA disease activity and vascular risk. Statins shows potential benefits in the prevention of articular inflammation.
出处 《中国新药杂志》 CAS CSCD 北大核心 2005年第11期1269-1272,共4页 Chinese Journal of New Drugs
关键词 他汀娄药物 炎性关节炎 免疫调节 statins inflammatory arthritis immunomodulation
  • 相关文献

参考文献11

  • 1Mclnnes IB, McCarey DW, Sattar N. Do statins offer therapeutic potential in inflammatory arthritis? [J]. GAnn Rheum DisG ,2004,63(12): 1535 - 1537.
  • 2Van Doornum S, McColl G, Wicks IP. Accelerated atherosclerosis:an extraarticular feature of rheumatoid arthritis? [ J ]. Arthritis Rheum ,2002,46(4): 862 - 873.
  • 3Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholestrol concentrations, in the Anglo-Scandinavian Cardiac Outcome Trial-Lipid Lowering Arm (ASCOTLLA): a multicenter randomized controlled trial[J]. Lancet,2003,361(9364): 1149 - 1158.
  • 4Leung BP, Sattar N, Crilly A, et al. A novel anti-inflammatory role for simvastatin in inflammatory arthritis [ J ]. J lmmunol, 2003,170(3): 1524 - 1530.
  • 5Yilmaz A,Reiss C, Tantawi O, et al. HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis[J]. Atherosclerosis ,2004,172( 1 ) :85 - 93.
  • 6Sattar N, McCarey DW, Capell H, et al. Explaining how "highgrade" systemic inflammation accelerates vascular risk in rheumatoid arthritis[J]. Circulation, 2003, 108(24) :2957 - 2963.
  • 7Choi HK,Hernan MA, Seeger JD, et al. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study [J]. Lancet,2002,359(9313): 1173 - 1177.
  • 8Hurlimann D,Forster A, Noll G, et al. Anti-tumor necrosis factoralpha treatment improves endothelial function in patients with rheumatoid arthritis[J]. Circulation, 2002,106(17) :2184 - 2187.
  • 9Svenson KL, Pollare T, Lithell H, et al. Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance[J]. Metabolism, 1988, 37(2): 125 - 130.
  • 10Vollmer T, Key L, Durkalski V, et al. Oral simvastatin treatment in relapsing-remitting multiple sclerosis [ J ]. Lancet, 2004,363 (9421):1607- 1608.

同被引文献47

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部